Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Resilinc Announces Chris Lanier as New Chief Technology Officer
-
Spur Therapeutics Publishes Preclinical Proof-of-Concept Data for SBT101, its Gene Therapy Candidate in Adrenomyeloneuropathy (AMN)
-
Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research’s Distinguished Investigator Award
-
Vertex Advances Tax Technology Innovation at Exchange 2024
-
Esperion Announces a Featured Presentation in the Late Breaker/Featured Science Track and Three Poster Presentations Accepted for the 2024 American Heart Association (AHA) Scientific Sessions
-
VEON to release 3Q 2024 trading update on 14 November 2024
-
Evaxion announces business update and third quarter 2024 financial results
-
Oxford BioTherapeutics to Present at World ADC Conference 2024
-
Eagle Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan
-
Foresight Ventures Co-hosts Neo X Grind Hackathon, Accessing $22 Million Funding to Propel Blockchain Innovation and Adoption
-
BioNTech to Host Innovation Series R&D Day on November 14, 2024
-
Stack Capital Group Inc. Reports Q3-24 Financial Results
-
BioNTech to Host Innovation Series R&D Day on November 14, 2024
-
Appendix 4C – Q1 FY25 Quarterly Cash Flow Report
-
Form 8.3 - I3 ENERGY PLC
-
Parker Reports Fiscal 2025 First Quarter Results
-
CoreCard Corporation Reports Third Quarter 2024 Results
-
500 Cycles Major Milestone: Novacium’s Silicon-Based Anode Batteries Demonstrate High Capacity and High Durability
-
Red Pine Discovers Significant Gold Mineralization in Faulted Extension of the Jubilee Shear on the Wawa Gold Project
-
Notice of Knight Therapeutics' Third Quarter 2024 Results Conference Call
-
Tourmaline Bio to Present at Upcoming Investor Conferences
-
InHouse by MariMed Launches Help on the Homefront, to Support Veterans Facing Housing Challenges
-
Psyence Biomedical Announces Closing of Previously Announced Acquisition of Psyence Group’s Stake in PsyLabs
-
Kura Oncology to Report Third Quarter 2024 Financial Results
-
Angus Gold Commences Fall Drilling Program on Dorset Gold Zone, Golden Sky Project, Wawa
-
Repligen to Report Third Quarter 2024 Financial Results
-
Kymera Therapeutics Announces Third Quarter 2024 Financial Results and Provides a Business Update
-
Intellia Therapeutics Announces Two Upcoming Investor Events in November 2024
-
InflaRx to Report Third Quarter 2024 Financial Results on November 8 and to Participate in Guggenheim Inaugural Healthcare Innovation Conference
-
ZenaTech’s ZenaDrone Completes the First Phase of an IQ Nano Inventory Management Trial for Multinational Auto Parts Customer
-
Cyber A.I. Group Featured in The Silicon Review Highlighting CyberAI’s Strategic Global Expansion
-
SIGA to Host Business Update Call on November 7 Following Release of Third-Quarter 2024 Financial Results
-
Zevra Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Nov. 12, 2024
-
Laureate Education Reports Financial Results For the Third Quarter and Nine Months Ended September 30, 2024
-
Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure
-
Stardust Power Engages MUFG as Lead Financial Advisor for Its Battery-Grade Lithium Refinery in Oklahoma
-
Bombardier Defense Proudly Delivers Eighth Global Aircraft to the U.S. Air Force Battlefield Airborne Communications Node Program
-
OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET
-
Scorpius Holdings Announces Implementation of New Cost Savings Measures Expected to Save Over $2 Million Annually
-
Innventure, Inc. to Announce Third Quarter 2024 Results on November 14
-
Nephros Schedules Third Quarter 2024 Financial Results Conference Call
-
Teva Statement on European Commission Decision; Company to Appeal
-
World Innovation League Launches DTTP 2.0: Empowering the Next Generation of Tech Talent in Canada
-
Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission
-
HII Reports Third Quarter 2024 Results and Provides Updated Outlook
-
PropW Kicks Off Global Tour: Highlights from Events in Malaysia, Taiwan, and Nigeria
-
Anika Reports Third Quarter 2024 Financial Results
-
Clearside Biomedical to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Tuesday, November 12, 2024
-
Canadians Crown Winning Design in 2024 Cashmere Collection after Inaugural Nationwide Live Vote
-
Emerita Provides Results for Phase 2 Metallurgical Testing Program at Iberian Belt West Project

